News & Updates
Filter by Specialty:
Sacituzumab govitecan improves survival in advanced breast cancer
Treatment with sacituzumab govitecan (SG), a novel antibody-drug conjugate, provides survival benefits in women diagnosed with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) breast cancer, reports a study.
Sacituzumab govitecan improves survival in advanced breast cancer
18 Nov 2024
Socioeconomic status tied to low use of adjuvant immunotherapy in stage III melanoma
Patients with stage III melanoma show inconsistent use of adjuvant immunotherapy despite its survival benefits, according to a study.
Socioeconomic status tied to low use of adjuvant immunotherapy in stage III melanoma
17 Nov 2024
Topical estriol gel prevents UTI, improves vaginal health in postmenopausal women
Ultra-low-dose 0.005 % estriol vaginal gel helps reduce the incidence of recurrent urinary tract infections (UTIs) and improve vaginal pH in postmenopausal women with genitourinary syndrome of menopause (GSM), as reported in a study.
Topical estriol gel prevents UTI, improves vaginal health in postmenopausal women
15 Nov 2024
AD trial: Cognitive impairment exacerbated with reduced iron in brain
Brain iron-lowering therapy with deferiprone appears to do more harm than good in patients with Alzheimer's disease (AD), being associated with increased cognitive decline in a phase II study.